$RPD

Why Rapid7 (RPD) Stock Is Trading Up Today

Rapid7 (NASDAQ: RPD) shares rose 26.9% after its Q2 2026 results showed an adjusted EPS of $0.44 vs $0.35 expected and adjusted EBITDA of $35.85M vs $31.93M. Revenue was $210.9M, up slightly but down 1.5% YoY. The company raised full-year adjusted EPS guidance to $1.81 midpoint, despite ARR down 2% and billings down 5.7%.

Original reporting
Published Aug 11, 2026, 5:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Rapid7 (RPD) Stock Is Trading Up Today — source image
Decision brief

The 30-second read

$RPDBullishHigh
01

Why it matters

The core tradable catalyst is the combination of an adjusted EPS and EBITDA beat and a raised full-year adjusted EPS guidance, which can override concerns about declining ARR/billings and softer Q3 revenue guidance.

02

Market read

Traders can reprice Rapid7 on raised full-year profit guidance and margin/FCF strength, while monitoring whether the disclosed ARR and billings declines reverse.

03

What to watch

Workforce reduction and a CEO transition can create execution risk; the article also cites AI partnerships (OpenAI/Anthropic) but does not quantify revenue contribution from those integrations.

Relevance 9/10Novelty 9/10Timing: morning session after Q2 results and raised full-year guidance

Background

Rapid7 is undergoing a restructuring-like pivot under newly appointed CEO Wael Mohamed, including a 12% workforce reduction and a focus on Detection and Response platforms.

Company-level read

Ticker impact

$RPDBullishHigh confidence
Context

Rapid7 reported Q2 2026 adjusted EPS of $0.44 vs $0.35 expected and raised full-year adjusted EPS guidance to $1.81 midpoint.

Expected impact

Near-term bias remains upward while traders digest the raised full-year EPS and margin/FCF strength, but expect volatility given ARR and billings declines plus softer Q3 revenue guidance.

Evidence & confidence

The article provides specific, time-sensitive financial beats and guidance changes, and contrasts them with deteriorating growth metrics that can cap follow-through.

Market effects

Reinforces the market narrative that cybersecurity vendors can sustain profitability even with slower top-line growth, supporting sentiment toward the group.

No specific regional impact beyond general US tech/cyber sentiment.

No explicit global catalyst; AI integration and guidance are company-specific.

Counterpoint

The profitability beat may be partly transitional, with ARR down 2% and billings down 5.7% plus slightly soft Q3 revenue guidance, suggesting the rally could fade if growth re-accelerates slower than expected.

Key entities

  • Rapid7

    Cybersecurity software provider whose Q2 2026 results and raised full-year guidance drove a 26.9% morning jump.

  • Wael Mohamed

    New CEO who announced a 12% workforce reduction and a pivot toward core Detection and Response platforms.

  • OpenAI

    Referenced as integrated GPT-5.5 into Rapid7 security workflows.

  • Anthropic

    Referenced via inclusion in “Project Glasswing” for automated vulnerability patching using Claude Mythos.

Related articles

$RPDMedAI 8/10

Rapid7 layoffs: Boston cybersecurity firm cuts 300 jobs

Rapid7 said it cut about 300 jobs, or 12% of its workforce, in Q2, announced with its second-quarter earnings. The company reported 2025 revenue of $860 million and forecast 2026 sales of $837 million at the low end. Rapid7 said the layoffs will cost $11 million to $12 million, mainly for severance. Shares rose 6% in aftermarket trading.

$RPDMedAI 8/10

Why is Rapid7 stock rallying today?

Rapid7 shares rose about 5.1% pre-open after the company reported Q2 2026 results that beat expectations, with adjusted EPS of $0.44 vs $0.35 and revenue of $210.9M vs $208.2M. Rapid7 raised full-year adjusted EPS guidance to $1.78–$1.83 and Q3 EPS to $0.44–$0.47, and approved a restructuring plan cutting staff ~12%.

$RPDMedAI 8/10

Expected Sales In Q2 CY2026, Stock Soars

Rapid7 (NASDAQ:RPD) reported Q2 CY2026 revenue of $210.9 million, down 1.5% year on year but 1.4% above estimates. Next-quarter revenue guidance is $209 million, about 0.9% below analysts. Non-GAAP EPS was $0.44, 26.3% above consensus. The stock rose 6.1% to $12.34 after results.

$RPDHighAI 9/10

Rapid7, Inc. (RPD): Results of Operations and Financial Condition

Rapid7, Inc. (RPD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026rapid78-kex991.htm EX-99.1 Document Exhibit 99.1 Rapid7 Announces Second Quarter 2026 Financial Results • Annualized recurring revenue (“ARR”) of $824 million • Total revenue of $211 million; Product subscriptions revenue of $205 million • GAAP income from operati

$OFIXMed

These 7 Small Caps Are On Fire In July: Here's Why - ExxonMobil Holdings (NYSE:XOM), Vertex Pharmaceutica

The Russell 2000 stayed near 3,000 with little movement, while seven small-cap stocks gained at least 28% in four sessions. The article cites July surges for Orthofix (OFIX) on CMS reimbursement reversal, REGENXBIO (RGNX) on FDA resubmission alignment and AbbVie milestone, Verastem (VSTM) on short-squeeze setup, ADC Therapeutics (ADCT) rebound, Sable Offshore (SOC) refinancing, Rapid7 (RPD) takeover speculation, and Crinetics (CRNX) surge toward an offer price.

$RPDMedAI 8/10

Rapid7 (RPD) Stock Trades Down, Here Is Why

Rapid7 (NASDAQ: RPD) shares fell 11.3% in the morning after Morgan Stanley downgraded the stock from Equal Weight to Underweight and kept a $9 price target. The firm cited competitive pressure in vulnerability management from AI-focused rivals and said Rapid7 has lagged in exposure management and real-time remediation. RPD is down 26.5% YTD.